Lucira Health to Participate in LifeSci Partners HealthTech Symposium
September 07 2022 - 7:00AM
Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical
technology company focused on the development and commercialization
of transformative and innovative infectious disease test kits,
and a digital health platform that will connect patients with
providers, today announced that the company will participate in the
LifeSci Partners HealthTech Symposium on September 21st, 2022, at
10:30am ET. A live and archived webcast of the event can be
accessed through the Events and Presentations page of the Lucira
website.
About Lucira HealthLucira is a medical
technology company focused on the development and commercialization
of innovative infectious disease tests to make lab-quality
diagnostics more accessible. Lucira designed its test platform to
provide accurate, reliable, PCR-quality test results anywhere and
at any time. Beyond its already commercialized COVID-19 and
COVID-19 & Flu Tests, Lucira is working on new diagnostic tests
for respiratory infections and other categories including women’s
health and sexually transmitted infections (STIs). For more
information, visit www.lucirahealth.com.
Investor ContactGreg
ChodaczekInvestorrelations@lucirahealth.com 332-895-3230
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jul 2023 to Jul 2024